Could a shot make peanut allergy treatment safer and more effective?
NCT ID NCT07015996
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 35 times
Summary
This study tests whether adding tezepelumab (an injected drug) to peanut oral immunotherapy (OIT) helps people with peanut allergy tolerate more peanut without symptoms. About 62 people aged 12–55 who react to tiny amounts of peanut will receive either tezepelumab or placebo for 8 weeks, then both groups start peanut OIT for 56 weeks. After stopping all treatment for 12 weeks, they will be tested to see if they can eat a large amount of peanut without a reaction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEANUT ALLERGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology
Little Rock, Arkansas, 72202, United States
-
Boston Children's Hospital: Allergy and Asthma Program
Boston, Massachusetts, 02115, United States
-
Cincinnati Children's Hospital Medical Center: Division of Allergy and Immunology
Cincinnati, Ohio, 45229, United States
-
Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology
New York, New York, 10029-6574, United States
-
Johns Hopkins Children's Center: Department of Allergy & Immunology
Baltimore, Maryland, 21287, United States
-
Massachusetts General Hospital: Department of Medicine: Allergy & Clinical Immunology Unit
Boston, Massachusetts, 02114, United States
-
North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology
Chapel Hill, North Carolina, 27599, United States
-
The University of Michigan: Division of Allergy and Clinical Immunology
Ann Arbor, Michigan, 48105, United States
-
University of California, Los Angeles: Department of Medicine, Division of Clinical Immunology and Allergy
Los Angeles, California, 90095, United States
-
University of Texas Southwestern Medical Center: Division of Allergy and Immunology
Dallas, Texas, 75390-9063, United States
Conditions
Explore the condition pages connected to this study.